TM-P4-Thal

For research use only. Not for therapeutic Use.

  • CAT Number: I037363
  • Molecular Formula: C50H74N6O10S
  • Molecular Weight: 951.23
  • Purity: 98%
Inquiry Now
TM-P4-Thal(Cat No.:I037363)is a compound that combines thalidomide with a novel peptide-based moiety (TM-P4), designed to enhance its therapeutic potential. Thalidomide is known for its anti-inflammatory, immunomodulatory, and antiangiogenic properties, primarily used in conditions like multiple myeloma and leprosy. TM-P4-Thal is being studied for its potential to improve thalidomide’s targeting ability, increasing its effectiveness in treating diseases such as cancer, inflammatory disorders, and autoimmune diseases. The peptide component aims to improve the selectivity and efficacy of thalidomide while potentially reducing its side effects. Ongoing research is exploring its clinical applications.

Catalog Number I037363
Synonyms

TM-P4-Thal; TMP4-Thal; TM P4-Thal; TM-P4Thal; TM-P4 Thal; TMP4Thal; TM P4 Thal;

Molecular Formula C50H74N6O10S
Purity 98%
Solubility Soluble in DMSO
Appearance Solid powder
Storage Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
IUPAC Name 1-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-N-((S)-1-oxo-1-(phenylamino)-6-tetradecanethioamidohexan-2-yl)-3,6,9,12-tetraoxapentadecan-15-amide
InChI InChI=1S/C50H74N6O10S/c1-2-3-4-5-6-7-8-9-10-11-15-24-45(67)52-28-17-16-22-41(47(59)53-38-19-13-12-14-20-38)54-44(58)27-30-63-32-34-65-36-37-66-35-33-64-31-29-51-40-23-18-21-39-46(40)50(62)56(49(39)61)42-25-26-43(57)55-48(42)60/h12-14,18-21,23,41-42,51H,2-11,15-17,22,24-37H2,1H3,(H,52,67)(H,53,59)(H,54,58)(H,55,57,60)/t41-,42?/m0/s1
InChIKey CYVGGMWMJPYYNF-DYJLHVNUSA-N
SMILES O=C(N[C@@H](CCCCNC(CCCCCCCCCCCCC)=S)C(NC1=CC=CC=C1)=O)CCOCCOCCOCCOCCNC2=CC=CC(C(N3C(CC4)C(NC4=O)=O)=O)=C2C3=O

Request a Quote